MEX3D expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.941000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.909400E-01
Normal-vs-Stage2
3.847800E-01
Normal-vs-Stage3
6.397000E-01
Normal-vs-Stage4
3.932800E-01
Stage1-vs-Stage2
2.448200E-02
Stage1-vs-Stage3
5.508200E-01
Stage1-vs-Stage4
5.675600E-02
Stage2-vs-Stage3
8.633600E-01
Stage2-vs-Stage4
6.681200E-01
Stage3-vs-Stage4
9.889000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.064400E-01
Normal-vs-AfricanAmerican
6.874000E-01
Normal-vs-Asian
3.432800E-01
Caucasian-vs-AfricanAmerican
6.749600E-01
Caucasian-vs-Asian
3.000600E-01
AfricanAmerican-vs-Asian
3.962600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.970600E-01
Normal-vs-Female
4.129400E-01
Male-vs-Female
8.562600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.543800E-01
Normal-vs-Age(41-60Yrs)
2.216800E-01
Normal-vs-Age(61-80Yrs)
5.397200E-01
Normal-vs-Age(81-100Yrs)
3.923400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.032200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.220400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.628400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.285900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.358800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.201000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.916800E-01
Normal-vs-Daily Drinker
4.055800E-01
Normal-vs-Weekly Drinker
1.488630E-01
Normal-vs-Occasional Drinker
2.266000E-01
Normal-vs-Social Drinker
5.437800E-01
Non Drinker-vs-Daily Drinker
9.794200E-01
Non Drinker-vs-Weekly Drinker
1.107250E-01
Non Drinker-vs-Occasional Drinker
8.005800E-01
Non Drinker-vs-Social Drinker
4.396200E-01
Daily Drinker-vs-Weekly Drinker
1.416770E-01
Daily Drinker-vs-Occasional Drinker
8.303000E-01
Daily Drinker-vs-Social Drinker
4.464800E-01
Weekly Drinker-vs-Occasional Drinker
1.402370E-01
Weekly Drinker-vs-Social Drinker
2.990400E-02
Occasional Drinker-vs-Social Drinker
2.335400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.984000E-01
Normal-vs-Grade 2
3.370800E-01
Normal-vs-Grade 3
6.847600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.565690E-02
Grade 1-vs-Grade 3
5.516800E-03
Grade 1-vs-Grade 4
8.984000E-01
Grade 2-vs-Grade 3
8.707200E-01
Grade 2-vs-Grade 4
3.370800E-01
Grade 3-vs-Grade 4
6.847600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.508400E-01
Normal-vs-NonDiabetic
2.607400E-01
Diabetic-vs-NonDiabetic
2.695200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.605000E-01
Normal-vs-NoPancreatitis
3.413800E-01
Pancreatitis-vs-NoPancreatitis
1.100810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.750000E-01
Normal-vs-N1
3.693800E-01
N0-vs-N1
4.381600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.491600E-01
Normal-vs-TP53-NonMutant
7.356600E-01
TP53-Mutant-vs-TP53-NonMutant
1.845430E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
